An interventional study of Exercise in COPD, Healthy and Lung Diseases, sponsored by Rigshospitalet, Denmark. Completed at 1 site in Denmark. Open to participants aged 40 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-24.
Sponsored by Rigshospitalet, Denmark · Not applicable, Interventional, and Basic science
Background:
The combined measurement of pulmonary diffusing capacity for carbon monoxide (CO) and nitric oxide (NO) (DL,CO,NO) has recently been standardized and validated for clinical use. It involves a noticeably short breath-hold time (≤5 seconds), making it feasible to perform on patients with chronic obstructive pulmonary disease (COPD). These patients have lower diffusing capacity and are unable to increase it during exercise, which is thought to be caused by changes in pulmonary perfusion potentially leading to exertional dyspnea. The aim of the present study is to examine whether pulmonary diffusing capacity for incremental exercise differs between patients with COPD and matched healthy controls.
Methods:
Inclusion of 12 individuals with mild-to-severe COPD and 12 healthy age- and sex-matched controls.
Design: Case-control study
Intervention: DL,CO,NO and arterial blood gases will be measured during exercise at a bicycle ergometer at 0, 20, 40, 60 and 80% of the individual's maximal workload.
Sample size: To detect a 15 mmol min-1 kPa-1 difference in DL,NO between groups at 60% of maximal workload, with a power of 90% and a significance level of 0.05, at least 12 subjects are required in each group. To account for potential dropouts, power will be permitted to decrease to 80%, corresponding to a total of 10 subjects in each group.
Statistical design: Linear mixed effect model and pairwise testing of estimated marginal means.
Perspective: This study will add to the understanding exertional dyspnoea in patients with COPD.
Introduction and background A pattern that applies to the majority of the more than 250 million people who suffer from chronic obstructive pulmonary disease (COPD) worldwide, is a downward spiral of exertional dyspnoea to poor quality of life, invalidity, and early death. A critical mechanism of exertional dyspnoea in these patients is thought to be reduced alveolar-capillary reserve, that is, a reduced ability to recruit and distend the pulmonary capillary bed to increase diffusing capacity upon an increase in cardiac output, which may be assessed by measuring the dual test pulmonary diffusing capacity (DL,CO,NO) during exercise. This technique permits up to 12 repeated manoeuvres within a session without affecting measurements, and it is thus ideal for assessing acute changes in pulmonary diffusing capacity and its components during various physiological manoeuvres. With this technique, the investigators have recently documented that alveolar-capillary recruitment, assessed by the change in the pulmonary diffusing capacity for nitric oxide (DL,NO) at a fixed workload of 60% of maximum, is blunted in COPD, seemingly in a severity-dependent fashion (unpublished observations). However, it is unknown whether this is already evident at low workloads, and/or whether it persists at near-maximal workloads, and it remains to be established to which extent this has an impact on pulmonary gas exchange, conventionally measured by the alveolar-arterial oxygen difference.
Aim The overall aim is to determine whether and how alveolar-capillary recruitment during incremental exercise differs between patients with mild-to-moderate COPD and healthy individuals.
Study design and recruitment 12 patients with mild-to-moderate COPD and 12 healthy age- and sex-matched controls will be included in the study, where DL,CO,NO will be measured at rest and during incremental workloads. Visit 0 consist of medical health interview and brief examination including blood pressure, heart rate and ECG measurement to investigate inclusion and exclusion criteria. Baseline measurements (Visit 1) will be performed to assess fitness and cardiopulmonary health status for the included patients and participants. The baseline measurements include cardiopulmonary exercise testing, lung function testing (dynamic spirometry, whole-body plethysmography and 10-second single-breath diffusing capacity for carbon monoxide), and an assessment of body composition. On Visit 2, which is at least two days later, an arterial catheter is inserted, after which DL,CO,NO and arterial blood gases are measured at rest, and at 20, 40, 60, and 80% of maximal workload on a bicycle ergometer, as determined during the cardiopulmonary exercise text on Visit 1.
Sample size Based on unpublished data in which a difference in DL,NO (mmol min-1 kPa-1) between COPD and control at 60% of maximal workload during cycling exercise, the power calculation was based on a two-sided independent samples t-test, with a power of 90% and a significance level (alpha) of 0.05. To detect a 15 mmol min-1 kPa-1 difference in DL,NO between groups at 60% of maximal workload, with a power of 90% and a significance level of 0.05, at least 12 subjects are required in each group. To account for potential dropouts, power will be permitted to decrease to 80%, corresponding to a total of 10 subjects in each group.
Statistical procedure The investigators will perform a linear mixed effect model with group and time as factors with participant as random effect accounting for repeated measures. The investigators will then perform pairwise testing of estimated marginal means from our mixed effect model to test for between group differences and within group differences. The investigators will perform Holm correction due to multiple testing.
General information This study is novel as it investigates pulmonary capillary recruitment in COPD, which is thought to be an important mechanism of exertional dyspnoea, which have primarily only been discussed in theoretical terms in previous studies. This study will be conducted in accordance with the regional ethical committee and the Declaration of Helsinki. Informed consent will be obtained from all study participants before enrolment and baseline testing.
Significance, novelty and expected impact The physiological assessments that are evaluated in the present study have the potential to be used provide information on the cause of dyspnoea in the individual COPD patient. This is relevant for the understanding of basic respiratory physiology and for designing future studies with interventions that aim to affect pulmonary capillary recruitment in COPD.
3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.
This study's enrollment of 24 is below the median of 72 across 2,118 interventional studies indexed under Lung Diseases.
Browse Lung Diseases studies →Rigshospitalet, Denmark is the lead sponsor of 1,017 studies on the registry; 183 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion criteria for COPD patients
Inclusion criteria for healthy participants
Exclusion criteria for COPD patients
Exclusion criteria for heathy controls
COPD-patients during diffusing capacity measurement during incremental exercise
Other: Exercise
Healthy matched controls during diffusing capacity measurement during incremental exercise
Other: Exercise
Exercise by bicycle and performing diffusing capacity measurements at the same time with arterial blood gasses.
Primary outcome
Between-group difference in the change in DL,NO from rest to exercise as a function of workload
Time frame: Measured at day 2
Key secondary outcome
Between-group difference in the change of the alveolar-arterial oxygen difference from rest to exercise as a function of workload
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change in DL,NO from rest to exercise as a function of VO2
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change of the alveolar-arterial oxygen difference from rest to exercise as a function of VO2
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change in cardiac output from rest to exercise as a function of workload
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change in stroke volume from rest to exercise as a function of workload
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change in heart rate from rest to exercise as a function of workload
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change in mean arterial blood pressure from rest to exercise as a function of workload
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change in cardiac output from rest to exercise as a function of VO2
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change in stroke volume from rest to exercise as a function of VO2
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change in heart rate from rest to exercise as a function of VO2
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change in mean arterial blood pressure from rest to exercise as a function of VO2
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change in PaO2 from rest to exercise as a function of workload and VO2
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change in SaO2 from rest to exercise as a function of workload and VO2
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change in PaCO2 from rest to exercise as a function of workload and VO2
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change in pH from rest to exercise as a function of workload and VO2
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change in base excess from rest to exercise as a function of workload and VO2
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change in lactate from rest to exercise as a function of workload and VO2
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change in respiratory rate from rest to exercise as a function of workload and VO2
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change in DL,CO,5s from rest to exercise as a function of workload and VO2
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change in DM from rest to exercise as a function of workload and VO2
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change in VC from rest to exercise as a function of workload and VO2
Time frame: Measured at day 2
Other secondary outcome
Between-group difference in the change in VA from rest to exercise as a function of workload and VO2
Time frame: Measured at day 2
Exploratory outcomes
Between-group difference in time constant (phase 2) (s) from VO2kinetics
Time frame: Measured at day 2
Exploratory outcomes
Between-group difference in mean response time (s) from VO2kinetics
Time frame: Measured at day 2
Exploratory outcomes
Between-group difference in amplitude (mLO2/min) from VO2kinetics
Time frame: Measured at day 2
Exploratory outcomes
Between-group difference in steady state gain (mLO2•min-1•watt-1) from VO2kinetics
Time frame: Measured at day 2
Exploratory outcomes
Between-group difference in time delay (phase 1) (s) from VO2kinetics
Time frame: Measured at day 2
Exploratory outcomes
Between-group difference in relative (mL/kg/min) VO2peak
Time frame: Measured at day 2
Exploratory outcomes
Between-group difference in absolute (mL/min) VO2peak
Time frame: Measured at day 2
Exploratory outcomes
Between-group difference in ventilatory threshold (%)
Time frame: Measured at day 2
Exploratory outcomes
Between-group difference in ventilatory reserve (%)
Time frame: Measured at day 2
Exploratory outcomes
Between-group difference in resistance (Rrs, R5-R20) measured by IOS
Time frame: Measured at day 2
Exploratory outcomes
Between-group difference in reactance (Xrs, X5) measured by IOS
Time frame: Measured at day 2
Exploratory outcomes
Between group difference in mean arterial pressure (MAP) as a function of workload.
Time frame: Measured at day 2
Exploratory outcomes
Between group difference in systolic blood pressure (SBP) as a function of workload.
Time frame: Measured at day 2
This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rigshospitalet, Denmark